Life  

SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED

30 SEPTEMBER 2018,
AND CASH DIVIDEND DECLARATION

Downloads

PDF DOWNLOADS

EXCEL DOWNLOADS

VIEW WEBCAST

Highlights


Revenue 
+12.9%
to R23.5 billion
Cash generated from operations
+18.0%
to R5.5 billion

Normalised EBITDA 
+10.7%
to R5.5 billion

Normalised earnings per share  
+17.4%
to 110.2 cents
Headline earnings per share
+40.6%
to 108.8 cents
Final dividend of 50 cents per share
+11.1%

Financials

Commentary

OVERVIEW

The Group results for the year ended 30 September 2018 reflect a strong overall performance with Group revenue growing by 12.9%, normalised EBITDA increasing by 10.7% and headline earnings per share up by 40.6%. The Group continues to diversify its revenue streams with 35% (2017: 28%) of Group revenue coming from outside the acute hospital business.